Key points are not available for this paper at this time.
macrophages. Unlike conventional PEGylation used for pharmacokinetic extension, this approach employs PEG as an active spatial modulator of peptide-cell interfaces. Overall, these results establish PEGylation-guided biointerface control as a rational design principle for polymer-peptide conjugates and demonstrate its potential for translational immunotherapy in autoimmune disease.
Song et al. (Thu,) studied this question.